Sponsor pipeline

89bio, Inc. clinical trial pipeline

Get alerts when 89bio, Inc.'s trials change

2 active trials 2 recruiting 2 Phase 3 1 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-08-06
Trial sites expanded: 317 → 321 locations
NCT06419374 A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With… · Phase 3
2026-08-06
Trial sites expanded: 361 → 365 locations
NCT06318169 A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and… · Phase 3

Active trials by phase

Phase 3
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT06318169 A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and… Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis Recruiting 2026-08-05
NCT06419374 A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With… Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis Recruiting 2026-08-05

Disease areas by active trials

NASH / MASH (2)

Get alerts when 89bio, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free